TRANSURETHRAL
COLLAGEN INJECTION FOR FEMALE STRESS INCONTINENCE
TRANSURETHRAL
COLLAGEN INJECTION FOR FEMALE STRESS INCONTINENCE
INTRODUCTION:
Urinary incontinence is a significant problem that affects
both sexes and all age groups, particularly the elderly. It
is estimated that approximately 10 to 12 million adults in
North America suffer from this problem. Urinary continence
is achieved because of greater urethral resistance remains
than intravesical pressure during bladder filling and that
increases in intra-abdominal pressure are transmitted approximately
equally to the bladder and proximal urethra. One of the mechanisms
that lead to stress urinary incontinence is that the urethra
no longer functions as a sphincter. This condition is now
called intrinsic sphincteric deficiency (ISD). The treatment
options for ISD include: sling operations, artificial sphincter,
or the injection of bulking material. The injection therapy
carries the advantages of being easy outpatient procedure
done mostly under local anesthesia with a very low complication
rate so, it is suitable to the incontinent population who
are usually old patients.
SURGICAL
TECHNIQUE:
1.) All injections were performed under local anesthesia assisted
with monitored anesthesia care (MAC), an intravenous combination
of fentanyl (an opioid analgesic), diprivan (a sedative hypnotic
agent) and midazolam (a short acting benzodiazepines) is given.
This type of sedation is smooth and short, allowing patients
to recover within minutes after cessation of the infusion.
A routine intravenous dose of broad-spectrum antibiotic was
given to every patient one hour before the procedure. After
injection, we continued a course of oral antibiotic for five
days.
2.) All injections were carried out transurethrally using
a cystoscope with a 20 F sheath and 30- degree lens. After
inspection of the urethra and bladder, a 5 F needle-tipped
catheter (C.R. Bard) is introduced through the working channel
of the cystoscope. The air bubbles in the catheter is displaced
while the needle is inside the bladder cavity until the collagen
paste appears as a fluffy material extruded from the needle.
The needle is then inserted just beneath the surface of the
mucosa, piercing the lamina propria but not the muscularis
layer. Usually injection is performed at 5 and 7 o'clock,
proximal to the external sphincter and distal to the bladder
neck. If the needle is placed into the correct submucosal
space, the collagen can speak circumferentially producing
excellent seal effect. In some other cases injection in multiple
sites is needed if the seal effect was unsatisfactory. Injection
should be slowly to allow the collagen to raise the mucosa
forming blebs till we observe obstruction of the urethral
lumen. In most cases, the final appearance is like a bilobar
prostate gland.
3). Once injection is completed, cystoscopic maneuvers are
minimized to prevent the molding of the urethra. The cystoscope
is removed and the bladder is emptied with a 10 F catheter.
All patients were discharged at the same day of injection
and kept on oral antibiotics for five days. If a patient developes
high residual urine, clean intermittent catheterization program
is instituted. If the patient is not satisfied with the results,
another injection is considered within 3 months with a maximum
of 3 injections.
RESULTS:
The cured and improved cases were 83.3% of which 70% needed
only one injection to achieve improvement, 25% needed 2 injections
while only 5% needed 3 injections. In the dry cases, the mean
cumulative volume of collagen injected per patient was 4.7
cc and the mean cumulative number of treatment sessions was
1.44, so, the mean volume of collagen injected per session
was 2.9cc. The overall average volume of collagen injected
per patient, in both the improved and cured patients, was
4.12 cc.
All patient tolerated the procedure well without any significant
side effects. We reported two cases of temporary urinary retention
as a complication. Both were managed with self intermittent
catheterization for less than one month.
CONCLUSION:
In conclusion, transurethral injection of collagen for internal
sphincteric deficiency is a safe and benign procedure. The
procedure can be easily repeated. The results, to date, are
encouraging and the long-term effectiveness is under study.